Archive - May 2019
FDA Approves Fragmin (dalteparin sodium) as First Anticoagulant for Venous Thromboembolism in Pediatric Patients
Working Memory Affected By Sleep And Mood, Study Finds
What The Chinese Rover Found On The Moon’s Dark Side
‘Avengers: Endgame’ Sparks Interest In Scientific Community
ICR launches ‘Darwinian’ cancer drug programme
New tech to protect prostate cancer patients during radiation treatment
Babylon expansion sparks ‘NHS destruction’ warnings
AZ confirms cardiovascular safety with roxadustat results